Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Australia
Emeritus Research Pty Ltd -Sydney, Botany, New South Wales Pendlebury Research Pty Ltd T/A Novatrials, Kotara, New South Wales Emeritus Research Pty Ltd -Melbourne, Camberwell, Victoria Taiwan
Chung Shan Medical University Hospital, Taichung, Taiwan Taipei Medical University Hospital, Taipei, Taiwan Chang Gung Memorial Hospital, Taoyuan District, Taiwan